1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSupports startups developing new technology in Georgia. It provides early capital to companies commercializing university research or solving real-world problems.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Georgia-based, innovative businesses in the early stages of development. Confirm the full requirements in the official notice before applying.
The current listing shows up to $10,000 for Exploratory Grants; Up to $250,000 for Development Grants. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Early Stage Innovation Fund is funded by Georgia Research Alliance (GRA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs) is sponsored by Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) and Neuroendocrine Tumor Research Foundation (NETRF). This grant supports early-career basic or clinical scientists to conduct novel and innovative research in nuclear medicine related to neuroendocrine tumors, with the aim of generating preliminary data for further funding.
The Merck Stimulating Innovative Research Grant Program 2026 includes a dedicated grant topic for artificial intelligence in cell culture media and process development, offering up to EUR 150,000 per year for up to 3 years. The program accelerates innovation through collaborative research, early engagement with industry experts, and translation of novel ideas into practical solutions. In 2026, priority areas also include in-vitro models for neuroinflammatory diseases (EUR 250,000/year for 2 years) and innovative approaches to contaminated materials remediation (EUR 150,000/year for 2 years). The two-stage application process begins with non-confidential submissions, followed by deep-dive workshops where finalists collaborate with Merck scientists and managers to jointly optimize proposals. The AI-specific grant focuses on applying machine learning and AI to optimize cell culture media formulation, bioprocess parameter optimization, and manufacturing quality control.